High blood cholesterol and drugs of ingredients of dasatinib - a phase IV clinical study of FDA data
Summary:
High blood cholesterol is found among people who take drugs with ingredients of dasatinib, especially for people who are male, 50-59 old , have been taking the drugs for 2 - 5 years. This phase IV clinical study is created by eHealthMe based on reports of 33,289 people who have side effects when taking drugs with ingredients of dasatinib from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Dasatinib, Sprycel.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
33,289 people reported to have side effects when taking drugs with ingredients of dasatinib.
Among them, 73 people (0.22%) have High blood cholesterol
What is High blood cholesterol?
High blood cholesterol is found to be associated with 3,561 drugs and 3,410 conditions by eHealthMe.
Number of reports submitted per year:

Time on drugs with ingredients of dasatinib when people have High blood cholesterol *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 6.25 %
- 1 - 2 years: 18.75 %
- 2 - 5 years: 68.75 %
- 5 - 10 years: 6.25 %
- 10+ years: 0.0 %
Gender of people who have High blood cholesterol when taking drugs with ingredients of dasatinib *:
- female: 46.48 %
- male: 53.52 %
Age of people who have High blood cholesterol when taking drugs with ingredients of dasatinib *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 2.08 %
- 40-49: 8.33 %
- 50-59: 60.42 %
- 60+: 29.17 %
Conditions people have *:
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 4.11%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 4.11%
- Pain: 2 people, 2.74%
- Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 1.37%
- Hypercalcaemia (elevated calcium (ca+) level in the blood): 1 person, 1.37%
- Back Pain: 1 person, 1.37%
- Bone Marrow Conditioning Regimen: 1 person, 1.37%
- Dizziness: 1 person, 1.37%
- Gastrointestinal Stromal Tumor: 1 person, 1.37%
- Glioma (a type of tumour that starts in the brain or spine): 1 person, 1.37%
Other drugs people take *:
- Tasigna: 18 people, 24.66%
- Crestor: 6 people, 8.22%
- Glivec: 6 people, 8.22%
- Lasix: 4 people, 5.48%
- Victoza: 3 people, 4.11%
- Viberzi: 3 people, 4.11%
- Valtrex: 3 people, 4.11%
- Valium: 3 people, 4.11%
- Xyrem: 3 people, 4.11%
- Prozac: 3 people, 4.11%
Other side effects people have besides High blood cholesterol *:
- Fatigue (feeling of tiredness): 30 people, 41.10%
- Breathing Difficulty: 23 people, 31.51%
- High Blood Pressure: 22 people, 30.14%
- Itching: 21 people, 28.77%
- Nausea (feeling of having an urge to vomit): 20 people, 27.40%
- Diabetes: 19 people, 26.03%
- Diarrhea: 17 people, 23.29%
- Blood Glucose Increased: 15 people, 20.55%
- Weakness: 13 people, 17.81%
- Pleural Effusion (water on the lungs): 13 people, 17.81%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Drugs with ingredients of dasatinib, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on dasatinib. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Slow-K and Systemic Lupus Erythematosus Rash - 4 seconds ago
- Hyperparathyroidism Secondary and Transitional Cell Carcinoma - 4 seconds ago
- Paxil Cr vs. Risperidone - 5 seconds ago
- Tamsulosin and Docetaxel drug interaction - 10 seconds ago
- Meropenem and Cubicin drug interaction - 10 seconds ago
- Trelegy Ellipta and Eye Movements - Uncontrollable - 12 seconds ago
- Oxytocin and Dysgraphia - 13 seconds ago
- Biotin and Nearsightedness - 17 seconds ago
- Memantine Hydrochloride and Eye Haemorrhage - 18 seconds ago
- Escitalopram and Vitamin D3 drug interaction - 22 seconds ago